{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:34:33Z","timestamp":1791905673128,"version":"4.3.4"},"reference-count":66,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:p>Opioid-related overdose deaths have reached epidemic levels within the last decade. The efforts to prevent, identify, and treat opioid use disorders (OUDs) mostly focus on the outpatient setting. Despite their frequent overrepresentation, less is known about the inpatient management of patients with OUDs. Specifically, the perioperative phase is a very vulnerable time for patients with OUDs, and little has been studied on the optimal management of acute pain in these patients. The preoperative evaluation should aim to identify those with OUDs and assess factors that may interfere with OUD treatment and pain management. Efforts should be made to provide education and assistance to patients and their support systems. For those who are actively struggling with opioid use, the perioperative phase can be an opportunity for engagement and to initiate treatment. Buprenorphine, methadone, and naltrexone medication treatment for OUD and opioid tolerance complicate perioperative pain management. A multidisciplinary team approach is crucial to provide clinically balanced pain relief without jeopardizing the patient\u2019s recovery. This article reviews the existing literature on the perioperative management of patients with OUDs and provides clinical suggestions for the optimal care of this patient population.<\/jats:p>","DOI":"10.1213\/ane.0000000000003477","type":"journal-article","created":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T19:44:06Z","timestamp":1527709446000},"page":"539-547","source":"Crossref","is-referenced-by-count":128,"title":["Opioid Use Disorders: Perioperative Management of a Special Population"],"prefix":"10.1213","volume":"127","author":[{"given":"Emine Nalan","family":"Ward","sequence":"first","affiliation":[{"name":"Psychiatry"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora Naa-Afoley","family":"Quaye","sequence":"additional","affiliation":[{"name":"Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy E.","family":"Wilens","sequence":"additional","affiliation":[{"name":"Psychiatry"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230721","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJM198001103020221","article-title":"Addiction rare in patients treated with narcotics.","volume":"302","author":"Porter","year":"1980","journal-title":"N Engl J Med"},{"key":"R2-20230721","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1001\/jama.1995.03530230060032","article-title":"Quality improvement guidelines for the treatment of acute pain and cancer pain.","volume":"274","year":"1995","journal-title":"JAMA"},{"key":"R3-20230721","first-page":"1487","article-title":"Vital signs: overdoses of prescription opioid pain relievers.","volume":"60","author":"Paulozzi","year":"2011","journal-title":"CDC Morb Mortal Wkly Rep"},{"key":"R4-20230721","doi-asserted-by":"crossref","first-page":"401","DOI":"10.36076\/ppj.2010\/13\/401","article-title":"Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective.","volume":"13","author":"Manchikanti","year":"2010","journal-title":"Pain Physician"},{"key":"R6-20230721","first-page":"1445","article-title":"Increases in drug and opioid-involved overdose deaths\u2014United States, 2010\u20132015.","volume":"65","author":"Rudd","year":"2016","journal-title":"MMWR"},{"key":"R8-20230721","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC Guideline for prescribing opioids for chronic pain\u2013United States, 2016.","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"R15-20230721","first-page":"CD011117","article-title":"Opioid agonist treatment for pharmaceutical opioid dependent people.","author":"Nielsen","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"R16-20230721","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies\u2014tackling the opioid-overdose epidemic.","volume":"370","author":"Volkow","year":"2014","journal-title":"N Engl J Med"},{"key":"R17-20230721","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"R18-20230721","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/archgenpsychiatry.2011.121","article-title":"Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial.","volume":"68","author":"Weiss","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"R19-20230721","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0140-6736(03)12600-1","article-title":"1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial.","volume":"361","author":"Kakko","year":"2003","journal-title":"Lancet"},{"key":"R21-20230721","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.drugalcdep.2016.10.015","article-title":"Treatment utilization among persons with opioid use disorder in the United States.","volume":"169","author":"Wu","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"R22-20230721","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/ADM.0000000000000193","article-title":"A systematic review on the use of psychosocial interventions in conjunction with medications for the treatment of opioid addiction.","volume":"10","author":"Dugosh","year":"2016","journal-title":"J Addict Med"},{"key":"R23-20230721","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2147\/TCRM.S141332","article-title":"The challenge of perioperative pain management in opioid-tolerant patients.","volume":"13","author":"Coluzzi","year":"2017","journal-title":"Ther Clin Risk Manag"},{"key":"R24-20230721","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11673-017-9784-y","article-title":"Stigma and self-stigma in addiction.","volume":"14","author":"Matthews","year":"2017","journal-title":"J Bioeth Inq"},{"key":"R25-20230721","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0376-8716(00)00200-3","article-title":"Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent.","volume":"63","author":"Compton","year":"2001","journal-title":"Drug Alcohol Depend"},{"key":"R26-20230721","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.drugalcdep.2014.10.010","article-title":"Co-morbid pain and opioid addiction: long term effect of opioid maintenance on acute pain.","volume":"145","author":"Wachholtz","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"R27-20230721","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/ALN.0000000000001633","article-title":"To stop or not, that is the question: acute pain management for the patient on chronic buprenorphine.","volume":"126","author":"Anderson","year":"2017","journal-title":"Anesthesiology"},{"key":"R28-20230721","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/ALN.0b013e31823c1067","article-title":"Practice advisory for preanesthesia evaluation: a report by the American Society of Anesthesiologists Task Force on Preanesthesia Evaluation.","volume":"116","author":"Apflebaim","year":"2012","journal-title":"Anesthesiology"},{"key":"R29-20230721","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/ALN.0b013e31823c1030","article-title":"Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management.","volume":"116","year":"2012","journal-title":"Anesthesiology"},{"key":"R30-20230721","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7.","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"key":"R31-20230721","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/jama.282.18.1737","article-title":"Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.","volume":"282","author":"Spitzer","year":"1999","journal-title":"JAMA"},{"key":"R32-20230721","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1001\/archinte.158.16.1789","article-title":"The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test.","volume":"158","author":"Bush","year":"1998","journal-title":"Arch Intern Med"},{"key":"R33-20230721","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/archinternmed.2010.140","article-title":"A single-question screening test for drug use in primary care.","volume":"170","author":"Smith","year":"2010","journal-title":"Arch Intern Med"},{"key":"R34-20230721","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.drugalcdep.2013.02.034","article-title":"Catastrophic thinking and increased risk for prescription opioid misuse in patients with chronic pain.","volume":"132","author":"Martel","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"R35-20230721","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.drugalcdep.2012.06.032","article-title":"Risk for prescription opioid misuse among patients with a history of substance use disorder.","volume":"127","author":"Morasco","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"R36-20230721","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1037\/1040-3590.7.4.524","article-title":"The Pain Catastrophizing Scale: development and validation.","volume":"7","author":"Sullivan","year":"1995","journal-title":"Psychol Assess"},{"key":"R37-20230721","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","article-title":"Neurobiology of addiction: a neurocircuitry analysis.","volume":"3","author":"Koob","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"R38-20230721","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1526-4637.2005.00072.x","article-title":"Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool.","volume":"6","author":"Webster","year":"2005","journal-title":"Pain Med"},{"key":"R39-20230721","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMra1511480","article-title":"Neurobiologic advances from the brain disease model of addiction.","volume":"374","author":"Volkow","year":"2016","journal-title":"N Engl J Med"},{"key":"R40-20230721","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.drugalcdep.2016.06.024","article-title":"Chronic pain, craving, and illicit opioid use among patients receiving opioid agonist therapy.","volume":"166","author":"Tsui","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"R41-20230721","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1360-0443.2007.01759.x","article-title":"Persistent pain is associated with substance use after detoxification: a prospective cohort analysis.","volume":"102","author":"Larson","year":"2007","journal-title":"Addiction"},{"key":"R42-20230721","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/EJA.0b013e32835b822b","article-title":"Perioperative pain therapy in opioid abuse.","volume":"30","author":"Stromer","year":"2013","journal-title":"Eur J Anaesthesiol"},{"key":"R44-20230721","first-page":"127","article-title":"Acute pain management for patients receiving maintenance methadone or buprenorphine therapy.","volume":"48","author":"Alford","year":"2007","journal-title":"Ann Intern Med"},{"key":"R45-20230721","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/BF03016532","article-title":"Review article: perioperative pain management of patients on methadone therapy.","volume":"52","author":"Peng","year":"2005","journal-title":"Can J Anaesth"},{"key":"R46-20230721","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jpain.2015.12.008","article-title":"Management of postoperative pain: a clinical practice guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists\u2019 Committee on Regional Anesthesia, Executive Committee, and Administrative Council.","volume":"17","author":"Chou","year":"2016","journal-title":"J Pain"},{"key":"R51-20230721","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2014.07.035","article-title":"Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: implications for clinical use and policy.","volume":"144","author":"Greenwald","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"R52-20230721","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11916-016-0549-9","article-title":"New pain management options for the surgical patient on methadone and buprenorphine.","volume":"20","author":"Sen","year":"2016","journal-title":"Curr Pain Headache Rep"},{"key":"R53-20230721","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s12630-014-0193-y","article-title":"Perioperative management of a patient undergoing Clagett window closure stabilized on Suboxone\u00ae for chronic pain: a case report.","volume":"61","author":"Huang","year":"2014","journal-title":"Can J Anaesth"},{"key":"R54-20230721","doi-asserted-by":"crossref","first-page":"E261","DOI":"10.36076\/ppj\/2015.18.E261","article-title":"Effect of buprenorphine on total intravenous anesthetic requirements during spine surgery.","volume":"18","author":"Khelemsky","year":"2015","journal-title":"Pain Physician"},{"key":"R55-20230721","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/pme.12135","article-title":"Case report: acute pain control challenges with buprenorphine\/naloxone therapy in a patinet with compartment syndrome secondary to McArdle\u2019s disease.","volume":"14","author":"McCormick","year":"2013","journal-title":"Pain Med"},{"key":"R56-20230721","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.anclin.2016.01.005","article-title":"Managing opioid-tolerant patients in the perioperative surgical home.","volume":"34","author":"Wenzel","year":"2016","journal-title":"Anesthesiol Clin"},{"key":"R57-20230721","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/ACO.0000000000000052","article-title":"The perioperative management of patients maintained on medications used to manage opioid addiction.","volume":"27","author":"Bryson","year":"2014","journal-title":"Curr Opin Anaesthesiol"},{"key":"R58-20230721","article-title":"Buprenorphine and the Anesthesia Considerations: A Literature Review.","author":"Stern","year":"2015","journal-title":"Nurse Anesthesia Capstones"},{"key":"R59-20230721","first-page":"250","article-title":"Perioperative pain management for patients on chrnoic buprenoprhine: a case report.","volume":"3","author":"Chern","year":"2013","journal-title":"J Anesth Clin Res"},{"key":"R60-20230721","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/MJT.0b013e3181be0804","article-title":"Effectiveness of full agonist opioids in patients stabilized on buprenorphine undergoing major surgery: a case series.","volume":"17","author":"Kornfeld","year":"2010","journal-title":"Am J Ther"},{"key":"R61-20230721","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.arth.2016.01.032","article-title":"Total joint arthroplasty in patients taking methadone or buprenorphine\/naloxone preoperatively for prior heroin addiction: a prospective matched cohort study.","volume":"31","author":"Hansen","year":"2016","journal-title":"J Arthroplasty"},{"key":"R62-20230721","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/0310057X1304100212","article-title":"Pain relief and opioid requirements in the first 24 hours after surgery in patients taking buprenorphine and methadone opioid substitution therapy.","volume":"41","author":"Macintyre","year":"2013","journal-title":"Anaesth Intensive Care"},{"key":"R63-20230721","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure.","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"key":"R64-20230721","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ejpain.2010.03.002","article-title":"Intrapartum and postpartum analgesia for women maintained on buprenorphine during pregnancy.","volume":"14","author":"Meyer","year":"2010","journal-title":"Eur J Pain"},{"key":"R65-20230721","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/00952990902825413","article-title":"Management of acute postpartum pain in patients maintained on methadone or buprenorphine during pregnancy.","volume":"35","author":"Jones","year":"2009","journal-title":"Am J Drug Alcohol Abuse"},{"key":"R66-20230721","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ejpain.2011.08.008","article-title":"Peripartum pain management in opioid dependent women.","volume":"16","author":"H\u00f6flich","year":"2012","journal-title":"Eur J Pain"},{"key":"R67-20230721","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/ADM.0000000000000166","article-title":"American Society of Addiction Medicine (ASAM) National Practice Guideline for the use of medications in the treatment of addiction involving opioid use.","volume":"9","author":"Kampman","year":"2015","journal-title":"J Addict Med"},{"key":"R68-20230721","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1176\/ajp.2007.164.6.979","article-title":"Buprenorphine for postoperative pain following general surgery in a buprenorphine-maintained patient.","volume":"164","author":"Book","year":"2007","journal-title":"Am J Psychiatry"},{"key":"R70-20230721","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1046\/j.1460-9568.2003.02502.x","article-title":"Receptor-selective changes in mu-, delta- and kappa-opioid receptors after chronic naltrexone treatment in mice.","volume":"17","author":"Lesscher","year":"2003","journal-title":"Eur J Neurosci"},{"key":"R71-20230721","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/bmj.332.7534.132","article-title":"Naltrexone and problems in pain management.","volume":"332","author":"Vickers","year":"2006","journal-title":"BMJ"},{"key":"R72-20230721","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/j.1360-0443.2008.02252.x","article-title":"Precipitated withdrawal during maintenance opioid blockade with extended release naltrexone.","volume":"103","author":"Fishman","year":"2008","journal-title":"Addiction"},{"key":"R73-20230721","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.pbb.2008.02.006","article-title":"Overriding the blockade of antinociceptive actions of opioids in rats treated with extended-release naltrexone.","volume":"89","author":"Dean","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"R74-20230721","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0006-8993(90)90821-R","article-title":"Simultaneous development of opioid tolerance and opioid antagonist-induced receptor upregulation.","volume":"529","author":"Yoburn","year":"1990","journal-title":"Brain Res"},{"key":"R75-20230721","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1213\/XAA.0000000000000069","article-title":"Challenges in the perioperative management of the patient receiving extended-release naltrexone.","volume":"3","author":"Curatolo","year":"2014","journal-title":"A A Case Rep"},{"key":"R76-20230721","doi-asserted-by":"crossref","first-page":"657e","DOI":"10.1097\/PRS.0b013e31828277bd","article-title":"The clinical conundrum of perioperative pain management in patients with opioid dependence: lessons from two cases.","volume":"131","author":"Israel","year":"2013","journal-title":"Plast Reconstr Surg"},{"key":"R78-20230721","first-page":"CD002025","article-title":"Buprenorphine for managing opioid withdrawal.","author":"Gowing","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R79-20230721","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/add.13214","article-title":"Advancing patient-centered care for structurally vulnerable drug-using populations: a qualitative study of the perspectives of people who use drugs regarding the potential integration of harm reduction interventions into hospitals.","volume":"111","author":"McNeil","year":"2016","journal-title":"Addiction"},{"key":"R80-20230721","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.2105\/AJPH.2015.302885","article-title":"Leaving the hospital against medical advice among people who use illicit drugs: a systematic review.","volume":"105","author":"Ti","year":"2015","journal-title":"Am J Public Health"},{"key":"R81-20230721","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/jamainternmed.2014.2556","article-title":"Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial.","volume":"174","author":"Liebschutz","year":"2014","journal-title":"JAMA Intern Med"},{"key":"R82-20230721","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/jama.2015.3474","article-title":"Emergency department-initiated buprenorphine\/naloxone treatment for opioid dependence: a randomized clinical trial.","volume":"313","author":"D\u2019Onofrio","year":"2015","journal-title":"JAMA"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000539-201808000-00037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:19:47Z","timestamp":1786112387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201808000-00037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000003477","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}